Osteopenic bone cell response to strontium-substituted hydroxyapatite

Ionic substitution is a powerful tool to improve the biological performance of calcium phosphate based materials. In this work, we investigated the response of primary cultures of rat osteoblasts derived from osteopenic (O-OB) bone to strontium substituted hydroxyapatite (SrHA), and to hydroxyapatite (HA) as reference material, compared to normal (N-OB) bone cells. Strontium (Sr) and calcium (Ca) cumulative releases in physiological solution are in agreement with the greater solubility of SrHA than HA, whereas the differences between the two materials are levelled off in DMEM, which significantly reduced ion release. O-OB cells grown on SrHA exhibited higher proliferation and increased values of the differentiation parameters. In particular, Sr substitution increased the levels of proliferation, alkaline phosphatase, and collagen type I, and down-regulated the production of interleukin-6 of O-OB cells, demonstrating a promising future of SrHA in the treatment of bone lesions and defects in the presence of osteoporotic bone.

[1]  L. Alexander,et al.  X-Ray diffraction procedures for polycrystalline and amorphous materials , 1974 .

[2]  R. Franceschi,et al.  Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3‐E1 cells , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  S. Akira,et al.  Interleukin-6 and its receptor: a paradigm for cytokines. , 1992, Science.

[4]  P. Marie,et al.  An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen‐deficient rats , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  G. Gronowicz,et al.  Mineralization and the Expression of Matrix Proteins During In Vivo Bone Development , 1998, Calcified Tissue International.

[6]  P. Marie.  Cellular and molecular alterations of osteoblasts in human disorders of bone formation. , 1999, Histology and histopathology.

[7]  J. Aubin,et al.  Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro , 1999, Journal of cellular biochemistry.

[8]  R. Giardino,et al.  In Vitro Pathological Model of Osteopenia to Test Orthopaedic Biomaterials , 2000, Artificial cells, blood substitutes, and immobilization biotechnology.

[9]  A. Krajewski,et al.  The effect of osteopenia on the osteointegration of different biomaterials: histomorphometric study in rats , 2000, Journal of materials science. Materials in medicine.

[10]  W. Puhl,et al.  Proliferation and differentiation rates of a human osteoblast-like cell line (SaOS-2) in contact with different bone substitute materials. , 2001, Journal of biomedical materials research.

[11]  C. Christiansen,et al.  Incorporation and distribution of strontium in bone. , 2001, Bone.

[12]  M. Seibel,et al.  Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. , 2001, The Journal of clinical endocrinology and metabolism.

[13]  C. Bünger,et al.  Factors stimulating bone formation , 2001, European Spine Journal.

[14]  A. Krajewski,et al.  Biocompatibility and osseointegration in osteoporotic bone. , 2001, The Journal of bone and joint surgery. British volume.

[15]  A. Carpi,et al.  The femoral distal epiphysis of ovariectomized rats as a site for studies on osteoporosis: structural and mechanical evaluations. , 2002, Clinical and experimental rheumatology.

[16]  D. MacEwan.  TNF ligands and receptors – a matter of life and death , 2002, British journal of pharmacology.

[17]  R. Giardino,et al.  Osteoblasts Cultured from Osteoporotic Bone: A Comparative Investigation on Human and Animal‐Derived Cells , 2003, Artificial cells, blood substitutes, and immobilization biotechnology.

[18]  L. Rimondini,et al.  In Vitro Behaviour of Osteoblasts Cultured on Orthopaedic Biomaterials with Different Surface Roughness, Uncoated and Fluorohydroxyapatite-Coated, Relative to the in Vivo Osteointegration Rate , 2003, The International journal of artificial organs.

[19]  Shigeyuki Ebisu,et al.  Effects of α-TCP and TetCP on MC3T3-E1 proliferation, differentiation and mineralization , 2003 .

[20]  P. Marie.  Strontium ranelate: a novel mode of action optimizing bone formation and resorption , 2004, Osteoporosis International.

[21]  P. Ammann.  Strontium ranelate: A novel mode of action leading to renewed bone quality , 2004, Osteoporosis International.

[22]  Kwan Tat Steeve,et al.  IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. , 2004 .

[23]  G. Gronowicz,et al.  The effects of patient age on human osteoblasts' response to Ti–6Al–4V implants in vitro , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  A. Bigi,et al.  Normal and osteopenic bone-derived osteoblast response to a biomimetic gelatin-calcium phosphate bone cement. , 2006, Journal of biomedical materials research. Part A.

[25]  A. Bandyopadhyay,et al.  Preparation and cell–materials interactions of plasma sprayed strontium-containing hydroxyapatite coating , 2007 .

[26]  M. Gazzano,et al.  Strontium-substituted hydroxyapatite nanocrystals. , 2007 .

[27]  G. Babis,et al.  Biomaterial osseointegration enhancement with biophysical stimulation. , 2007, Journal of musculoskeletal & neuronal interactions.

[28]  Yann C. Fredholm,et al.  Structural analysis of a series of strontium-substituted apatites. , 2008, Acta biomaterialia.

[29]  M Fini,et al.  Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: in vitro osteoblast and osteoclast response. , 2008, Acta biomaterialia.

[30]  E. Landi,et al.  Development of Sr and CO3 co-substituted hydroxyapatites for biomedical applications. , 2008, Acta biomaterialia.

[31]  P. Halbout,et al.  Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response , 2009, Osteoporosis International.

[32]  F. Saltel,et al.  Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. , 2008, Bone.

[33]  D. Ellis,et al.  The structure of strontium-doped hydroxyapatite: an experimental and theoretical study. , 2009, Physical chemistry chemical physics : PCCP.

[34]  J. Reginster,et al.  Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. , 2009, Bone.

[35]  M. Gazzano,et al.  Interaction of Sr-doped hydroxyapatite nanocrystals with osteoclast and osteoblast-like cells. , 2009, Journal of biomedical materials research. Part A.

[36]  W. Lu,et al.  Solubility of strontium-substituted apatite by solid titration. , 2009, Acta biomaterialia.

[37]  F. Blanchard,et al.  The dual role of IL-6-type cytokines on bone remodeling and bone tumors. , 2009, Cytokine & growth factor reviews.

[38]  J. Zwerina,et al.  Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. , 2009, Arthritis and rheumatism.

[39]  M. Fernández-Gutiérrez,et al.  Biocompatibility of alendronate-loaded acrylic cement for vertebroplasty. , 2010, European cells & materials.

[40]  Gavin Jell,et al.  The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro. , 2010, Biomaterials.

[41]  M. Gazzano,et al.  Ionic substitutions in calcium phosphates synthesized at low temperature. , 2010, Acta biomaterialia.

[42]  J. Rodríguez,et al.  Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  S. Gallacher,et al.  Impact of Treatments for Postmenopausal Osteoporosis (Bisphosphonates, Parathyroid Hormone, Strontium Ranelate, and Denosumab) on Bone Quality: A Systematic Review , 2010, Calcified Tissue International.

[44]  A. Berdal,et al.  Effects of strontium-doped bioactive glass on the differentiation of cultured osteogenic cells. , 2011, European cells & materials.

[45]  E. Deeks,et al.  Strontium Ranelate , 2010, Drugs.